2022 Industry Education
Click here to access the education and symposia materials from industry contributors.
- MEDTRONIC SYMPOSIA
- ELI LILLY SYMPOSIA
Medtronic supported some exciting sessions at ATTD22:Medtronic Smart MDI system: A novel combination of smart insulin pen and CGM to improve type 1 diabetes management
In this session, Medtronic introduced their first Smart MDI system which combines real time CGM with predictive glucose alerts and personalized insulin dosing to help patients stay ahead of their glucose levels and take the right dose at the right time.
The session was chaired by Robert Vigersky, who also presented alongside Rainer Straβburger-Lausen, and Rocio Harbison.
Successful Initiation of the MiniMedTM 780G System in the Wider Population with Type 1 Diabetes
This practical session focused on how to onboard people with type 1 diabetes on the MiniMed™ 780G system, aiming to achieve the highest possible glycemic control while minimizing the demands on users and caretakers.
The session was chaired by Prof. Ohad Cohen, who also presented alongside Pilar I. Beato-Vibora and Henk Jan Aanstoot.
Eli Lilly supported two impressive sessions at ATTD22:
Lyumjev® and Tempo™: The Future of Multiple Daily Injection Therapy
This symposium introduced Tempo™, a Personalized Diabetes Management System and Lyumjev®, a fast-acting mealtime insulin from Eli Lilly.
Featuring Partha Kar as Chair, and Andreas Liebl and Pratik Choudhary as presenters.
Managing T2D – time to change the paradigm?- Industry Symposium Supported by Eli Lilly and Company.
This engaging symposium explored new clinical frontiers in the management of type 2 diabetes (T2D).
Chaired by Christophe de Block, the symposium consisted of two cutting-edge scientific presentations, followed by an open and interactive discussion session. With expert speakers Stefano Del Prato and Tadej Battelino.